Arti­kel 2021

Hoe­bel J, Busch MA, Grab­ka MM, Zinn S, Allen J, Göß­wald A, Wer­nitz J, Goe­bel J, Stein­hau­er HW, Sie­gers R, Schrö­der C, Kut­tig T, But­scha­low­sky H, Schlaud M, Schaf­frath Rosa­rio A, Brix J, Rysi­na A, Glem­ser A, Neu­hau­ser H, Stahl­berg S, Kneu­er A, Hey I, Schaar­schmidt J, Fie­big J, Butt­mann-Schwei­ger N, Wil­king H, Michel J, Nit­sche A, Wie­ler LH, Schaa­de L, Zie­se T, Lie­big S, Lam­pert T. Sero­epi­de­mio­lo­gi­sche Stu­die zur bun­des­wei­ten Ver­brei­tung von SARS-CoV‑2 in Deutsch­land: Stu­di­en­pro­to­koll von CORONA-MONITORING bun­des­weit (RKI-SOEP-Stu­die). J Health Mon 2021; 6 (S1). doi:10.25646/7852

Neu­hau­ser H, Schaf­frath Rosa­rio A, But­scha­low­sky H, Hal­ler S, Hoe­bel J, Michel J, Nit­sche A, Poeth­ko-Mül­ler C, Prütz F, Schlaud M, Stein­hau­er HW, Wil­king H, Wie­ler LH, Schaa­de L, Lie­big S, Göß­wald A, Grab­ka MM, Zinn S, Zie­se T. Germany’s low SARS-CoV‑2 sero­pr­e­va­lence con­firms effec­ti­ve con­tain­ment in 2020: Results of the nati­on­wi­de RKI-SOEP stu­dy. Pre­print. Medrxiv 2021. doi:10.1101/2021.11.22.21266711

Schien­kie­witz A, Jor­dan S, Horn­bä­cher A, Per­litz H, Zeis­ler ML, San­do­ni A, Kubisch U, Wess B, Kut­tig T, Schaf­frath Rosa­rio A, Dame­row S, Rat­tay P, Varn­ac­cia G, Loer AKM, Worms­bä­cher J, Cohr­des C, Wetz­stein M, Albrecht S, Hey I, Michel J, Schrick L, Göß­wald A, Allen J, Schlaud M, Busch MA, But­scha­low­sky H, Wer­nitz J, Otte im Kam­pe E, Buch­holz U, Haas W, Schaa­de L, Wie­ler LH, Zie­se T, Lam­pert T, Loss J. SARS-CoV‑2 trans­mis­si­bi­li­ty within day care centers—study pro­to­col of a pro­s­pec­ti­ve ana­ly­sis of out­breaks in Ger­ma­ny. Front Public Health 2021; 9. doi:10.3389/fpubh.2021.773850

Sper­le I, Niel­sen S, Bre­mer V, Gas­sow­ski M, Brum­mer-Kor­ven­kon­tio H, Bruni R, Rita Cic­ca­gli­o­ne AR, Kan­eva E, Liit­so­la K, Nan­eva Z, Per­chem­lie­va T, Spa­da E, Toik­ka­nen S, Ama­to-Gau­ci AJ, and Duf­fell E & Zim­mer­mann R, on behalf of the SPHERE‑C Expert Group*. Deve­lo­ping and pilo­ting a stan­dar­di­sed Euro­pean pro­to­col for hepa­ti­tis C pre­va­lence sur­veys in the gene­ral popu­la­ti­on (2016−2019). Front Public Health 2021; 9: 568524. doi:10.3389/fpubh.2021.568524

*) The SPHERE‑C Expert Group: Bar­ker L, Brouard C, Avel­lon Cal­vo AM, Girau­don I, Göß­wald A, Hah­né S, Hendrickx G, Hope V, Hut­chin­son S, Kas­rad­ze A, Kivi­te-Urta­ne A, van der Klis F, Lacom­be K, Main­e­ri A, Mar­cus U, Mozalevskis A, Muyl­der­mans G, Negro F, Popo­vici O, Rosins­ka M, Sabo­ni L, San­du­les­cu O, Schlaud M, Sey­ler T, Syp­sa V, Tavo­schi L, Thorn­ton L, Tolo­nen H, Tou­lo­u­mi G, Vin­ce A, Ner­lan­der L, Mar­kov P.


2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992

error: Content is protected.